Lisicki Robert Insider Trades

Insider Trading History

Track insider trading activity for Lisicki Robert. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Zura Bio
Zura Bio ZURA
Chief Executive Officer
Holding Value $4.96M 1,153,000 shares
Last Trade
Feb 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.38M 1,153,000 shares
$1.20
$4.30
Cadrenal Therapeutics
Cadrenal Therapeutics CVKD
Director
Holding Value $61.2k 20,000 shares
Last Trade
Jan 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$396k 20,000 shares
$19.79
$3.06
Zura Bio
Zura Bio ZURA
Chief Executive Officer
Holding Value $504k 117,000 shares
Last Trade
Dec 09, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$323k 117,000 shares
$2.76
$4.30
Zura Bio
Zura Bio ZURA
Chief Executive Officer
Holding Value $4.52M 1,050,000 shares
Last Trade
Jun 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.55M 1,050,000 shares
$3.38
$4.30
Zura Bio
Zura Bio ZURA
See Remarks
Holding Value $4.31M 1,000,000 shares
Last Trade
Jan 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.98M 1,000,000 shares
$3.98
$4.30
Cadrenal Therapeutics
Cadrenal Therapeutics CVKD
Director
Holding Value $153k 50,000 shares
Last Trade
Jan 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$705k 50,000 shares
$14.10
$3.06
Cadrenal Therapeutics
Cadrenal Therapeutics CVKD
Director
Holding Value $230k 75,000 shares
Last Trade
Jul 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.35M 75,000 shares
$17.97
$3.06
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Evp, Chief Commercial Officer
Holding Value $2.81M 28,122 shares
Last Trade
Mar 11, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$3.76M 37,563 shares
$99.99
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Evp, Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Mar 11, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$30.9M 309,050 shares
$99.99
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Evp, Chief Commercial Officer
Holding Value $3.76M 37,563 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2M 21,462 shares
$93.19
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Evp, Chief Commercial Officer
Holding Value $11M 110,000 shares
Last Trade
Aug 03, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.06M 17,500 shares
$60.43
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Evp, Chief Commercial Officer
Holding Value $2.8M 27,996 shares
Last Trade
Aug 03, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.05M 17,500 shares
$60.08
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Evp, Chief Commercial Officer
Holding Value $3.36M 33,601 shares
Last Trade
Aug 03, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.06M 17,500 shares
$60.43
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Evp, Chief Commercial Officer
Holding Value $3.88M 38,850 shares
Last Trade
Mar 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.86M 60,710 shares
$80.08
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Evp, Chief Commercial Officer
Holding Value $12.7M 127,500 shares
Last Trade
Feb 02, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.39M 17,500 shares
$79.34
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Evp, Chief Commercial Officer
Holding Value $2.69M 26,941 shares
Last Trade
Feb 02, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.39M 17,500 shares
$79.34
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Evp, Chief Commercial Officer
Holding Value $2.52M 25,200 shares
Last Trade
Feb 02, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.38M 17,500 shares
$78.88
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Evp, Chief Commercial Officer
Holding Value $944k 9,441 shares
Last Trade
Jan 07, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$245k 3,159 shares
$77.59
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Evp, Chief Commercial Officer
Holding Value $1.26M 12,600 shares
Last Trade
Jan 07, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$978k 12,600 shares
$77.59
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Evp, Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Jan 07, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$978k 12,600 shares
$77.59
$99.99

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up